AFP and hepatocellular carcinoma: GALAD score (calculated using gender, age, AFP, L3-AFP, and Des-carboxy-prothrombin) is a statistical model used for the early prediction of HCC development in patients with chronic hepatitis B. The association of the GALAD score with imaging-based techniques can generate better information for high-risk patient monitoring [111].